US stock screener
Every US-listed company we cover. Most columns are company-reported figures from each company’s own SEC filings; P/E, market cap and dividend yield are market-derived, combining SEC share counts and TTM results with a stored price, last retrieved on a rolling basis and typically within the past week. Click a column to sort, or open a company for its full statements with per-figure provenance.
All sectorsTechnologyFinancialsHealthcareConsumer DiscretionaryConsumer StaplesEnergyIndustrialsMaterialsUtilitiesReal EstateCommunication Services
570 companies in Healthcare · page 4 of 6
| Company | Sector | Market cap | Revenue (FY) | Rev growth | Net margin | ROE | P/E (TTM) | Div yield |
|---|---|---|---|---|---|---|---|---|
| Neuronetics, Inc. (STIM) | Healthcare | $160.8Mpit | $149.2M | 99.2% | -26.1% | -148.6% | — | — |
| Elite Pharmaceuticals Inc. (ELTP) | Healthcare | $269.3Mpit | $148.9M | 77.1% | 30.1% | 45.4% | — | — |
| GRAIL, Inc. (GRAL) | Healthcare | $5.68Bpit | $147.2M | 17.2% | — | -15.8% | — | — |
| Cronos Group Inc. (CRON) | Healthcare | $1.25Bpit | $146.6M | 24.6% | -6.4% | -0.8% | — | — |
| Karyopharm Therapeutics Inc. (KPTI) | Healthcare | $12.4Mpit | $146.1M | 0.6% | — | — | — | — |
| InfuSystem Holdings, Inc (INFU) | Healthcare | $281.6Mpit | $143.4M | 6.4% | 4.6% | 11.6% | 34.7 | — |
| Natural Alternatives International Inc. (NAII) | Healthcare | $7.5Mvendor | $142.5M | 9.7% | -14.5% | -41.4% | — | — |
| Beam Therapeutics Inc. (BEAM) | Healthcare | $2.48Bpit | $139.7M | 120.0% | -57.2% | -6.5% | — | — |
| Quanterix Corp (QTRX) | Healthcare | $135.3Mpit | $138.9M | 1.1% | -77.1% | -36.2% | — | — |
| Nrc Health (NRC) | Healthcare | $472.9Mpit | $137.4M | -4.0% | 8.4% | 82.9% | — | 2.7% |
| RxSight, Inc. (RXST) | Healthcare | $208.8Mpit | $134.5M | -3.9% | -29.0% | -14.1% | — | — |
| Xtant Medical Holdings, Inc. (XTNT) | Healthcare | $39.6Mpit | $133.9M | 14.2% | 3.7% | 9.8% | — | — |
| Niagen Bioscience, Inc. (NAGE) | Healthcare | $199.4Mpit | $129.4M | 29.9% | 13.4% | 22.7% | 14.1 | — |
| Lifecore Biomedical, Inc. \de\ (LFCR) | Healthcare | $241.1Mpit | $128.9M | 0.5% | -30.0% | — | — | — |
| Xencor Inc (XNCR) | Healthcare | $1.87Bpit | $125.6M | 13.7% | -73.2% | -14.5% | — | — |
| Monte Rosa Therapeutics, Inc. (GLUE) | Healthcare | $947.8Mpit | $123.7M | 63.5% | -31.2% | -16.6% | — | 0.0% |
| Atara Biotherapeutics, Inc. (ATRA) | Healthcare | $93.9Mpit | $120.8M | -6.3% | 27.1% | — | — | — |
| Outset Medical, Inc. (OM) | Healthcare | $78.4Mpit | $119.5M | 5.1% | -68.3% | -64.3% | — | — |
| Gyre Therapeutics, Inc. (GYRE) | Healthcare | $653.4Mpit | $116.6M | 10.2% | 8.5% | — | — | — |
| Orasure Technologies Inc. (OSUR) | Healthcare | $253.8Mpit | $115.0M | -38.1% | -59.8% | -20.2% | — | — |
| Agenus Inc. (AGEN) | Healthcare | $278.2Mpit | $114.2M | 10.4% | -2.7% | — | — | — |
| ImmunityBio, Inc. (IBRX) | Healthcare | $8.81Bpit | $113.3M | 668.3% | — | — | — | — |
| Anika Therapeutics, Inc. (ANIK) | Healthcare | $286.7Mpit | $112.8M | -5.9% | -9.6% | -7.6% | — | — |
| Geospace Technologies Corp. (GEOS) | Healthcare | $54.7Mpit | $110.8M | -18.3% | -8.8% | -7.7% | — | — |
| UroGen Pharma Ltd. (URGN) | Healthcare | $1.69Bpit | $109.8M | 21.4% | — | — | — | — |
| Century Therapeutics, Inc. (IPSC) | Healthcare | $286.1Mpit | $109.2M | 1556.8% | -8.8% | -6.0% | — | — |
| Mannatech Inc. (MTEX) | Healthcare | $16.5Mpit | $108.0M | -8.3% | -14.1% | — | — | — |
| Theravance Biopharma, Inc. (TBPH) | Healthcare | $884.2Mvendor | $107.5M | 66.9% | 98.5% | 35.7% | — | — |
| Zevra Therapeutics, Inc. (ZVRA) | Healthcare | $582.6Mpit | $106.5M | 350.9% | 78.2% | 53.8% | 10.5 | — |
| Zymeworks Inc. (ZYME) | Healthcare | $2.00Bpit | $106.0M | 38.9% | -76.6% | -30.2% | — | — |
| Owlet, Inc. (OWLT) | Healthcare | $121.3Mpit | $105.7M | 35.4% | -37.5% | — | — | — |
| Sanara MedTech Inc. (SMTI) | Healthcare | $301.4Mpit | $103.1M | 19.0% | -36.4% | -633.5% | — | — |
| Sutro Biopharma, Inc. (STRO) | Healthcare | $154.7Mpit | $102.5M | 65.2% | — | — | — | — |
| Beta Bionics, Inc. (BBNX) | Healthcare | $827.8Mpit | $100.3M | 53.9% | -73.0% | -25.5% | — | — |
| NeuroPace Inc (NPCE) | Healthcare | $451.0Mpit | $100.0M | 25.1% | -21.5% | -112.8% | — | — |
| Butterfly Network, Inc. (BFLY) | Healthcare | $1.95Bpit | $97.6M | 19.0% | -79.0% | -39.3% | — | — |
| Biolife Solutions Inc. (BLFS) | Healthcare | $1.89Bvendor | $96.2M | 28.9% | -4.8% | -1.2% | — | — |
| Kestra Medical Technologies, Ltd. (KMTS) | Healthcare | $1.71Bpit | $95.1M | 59.0% | — | -50.7% | — | — |
| Siga Technologies Inc. (SIGA) | Healthcare | $224.2Mpit | $94.6M | -31.8% | 24.6% | 11.7% | — | 19.4% |
| Pulmonx Corp (LUNG) | Healthcare | $80.7Mpit | $90.5M | 8.0% | -59.7% | -99.8% | — | — |
| VASO Corp (VASO) | Healthcare | $51.0Mpit | $89.1M | 2.7% | 1.8% | 5.3% | — | — |
| Ceribell, Inc. (CBLL) | Healthcare | $1.04Bpit | $89.1M | 36.1% | -60.0% | -34.4% | — | — |
| Biodesix Inc. (BDSX) | Healthcare | $252.5Mpit | $88.5M | 24.1% | -39.8% | — | — | — |
| Cytokinetics Inc. (CYTK) | Healthcare | $8.74Bpit | $88.0M | 376.6% | — | — | — | — |
| Harvard Bioscience Inc. (HBIO) | Healthcare | $38.0Mpit | $86.5M | -8.1% | -65.5% | -412.8% | — | — |
| LakeShore Biopharma Co., Ltd. (LSBCF) | Healthcare | — | $85.7M | 6.0% | -16.3% | -20.0% | — | — |
| Standard Biotools Inc. (LAB) | Healthcare | $249.5Mpit | $85.3M | -6.2% | -87.8% | -17.7% | — | — |
| Delcath Systems, Inc. (DCTH) | Healthcare | $510.1Mpit | $85.2M | 129.1% | 3.2% | 2.4% | — | — |
| 4D Molecular Therapeutics, Inc. (FDMT) | Healthcare | $723.7Mvendor | $85.2M | 230194.6% | — | -27.7% | — | — |
| ARS Pharmaceuticals, Inc. (SPRY) | Healthcare | $400.8Mpit | $84.3M | -5.5% | — | -149.9% | — | — |
| Nurix Therapeutics, Inc. (NRIX) | Healthcare | $2.79Bpit | $84.0M | 54.0% | — | -49.1% | — | — |
| Iradimed Corp. (IRMD) | Healthcare | $1.12Bpit | $83.8M | 14.4% | 26.8% | 23.8% | 49.0 | 1.4% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | Healthcare | $296.2Mpit | $82.0M | -46.1% | -80.2% | -30.7% | — | — |
| Fitlife Brands, Inc. (FTLF) | Healthcare | $77.2Mpit | $81.5M | 26.4% | 7.8% | 14.5% | 43.7 | — |
| MeiraGTx Holdings plc (MGTX) | Healthcare | $938.3Mpit | $81.4M | 144.6% | — | — | — | — |
| ADC Therapeutics SA (ADCT) | Healthcare | $183.8Mpit | $81.4M | 14.9% | — | — | — | — |
| TELA Bio, Inc. (TELA) | Healthcare | $43.3Mpit | $80.3M | 15.8% | -48.4% | -615.1% | — | — |
| Eton Pharmaceuticals, Inc. (ETON) | Healthcare | $1.43Bpit | $80.0M | 104.9% | -5.8% | -17.6% | — | — |
| Pro Dex Inc. (PDEX) | Healthcare | $199.8Mpit | $77.5M | 16.5% | 17.6% | 28.7% | 15.2 | — |
| Sight Sciences, Inc. (SGHT) | Healthcare | $495.2Mpit | $77.4M | -3.1% | -49.7% | -60.1% | — | — |
| Burning Rock Biotech Ltd (BNR) | Healthcare | $133.5Mvendor | $77.2M | 9.2% | -10.3% | -10.3% | — | — |
| CytomX Therapeutics, Inc. (CTMX) | Healthcare | $523.0Mpit | $76.2M | -44.8% | -22.8% | -17.5% | — | — |
| Autolus Therapeutics plc (AUTL) | Healthcare | $431.2Mpit | $75.4M | 644.9% | — | -161.4% | — | — |
| AbCellera Biologics Inc. (ABCL) | Healthcare | $3.66Bpit | $75.1M | 160.6% | — | -15.1% | — | — |
| Recursion Pharmaceuticals, Inc. (RXRX) | Healthcare | $1.96Bpit | $74.7M | 26.9% | — | -57.0% | — | — |
| Electromed, Inc. (ELMD) | Healthcare | $224.8Mpit | $73.8M | 15.3% | 15.3% | 20.9% | 20.5 | — |
| Compugen Ltd. (CGEN) | Healthcare | $200.8Mvendor | $72.8M | 161.1% | 48.6% | 34.4% | — | — |
| Bicycle Therapeutics PLC (BCYC) | Healthcare | $249.9Mpit | $72.6M | 105.8% | — | -35.9% | — | — |
| Assembly Biosciences, Inc. (ASMB) | Healthcare | $410.5Mpit | $72.3M | 153.5% | -8.5% | -3.0% | — | — |
| AVITA Medical, Inc. (RCEL) | Healthcare | $479.7Mpit | $70.9M | 10.9% | -68.5% | — | — | — |
| Viridian Therapeutics, Inc.\DE (VRDN) | Healthcare | $2.53Bpit | $70.8M | 23359.9% | — | -47.4% | — | — |
| Edap Tms SA (FOCL) | Healthcare | $155.7Mpit | $70.5M | 1.6% | -41.5% | -150.7% | — | — |
| Black Diamond Therapeutics, Inc. (BDTX) | Healthcare | $119.5Mpit | $70.0M | — | 32.0% | 19.9% | — | — |
| Personalis, Inc. (PSNL) | Healthcare | $1.69Bpit | $69.6M | -17.7% | — | -31.1% | — | — |
| Rockwell Medical, Inc. (RMTI) | Healthcare | $28.0Mpit | $69.3M | -31.8% | -7.7% | -14.4% | — | — |
| Vir Biotechnology, Inc. (VIR) | Healthcare | $1.79Bpit | $68.6M | -7.6% | — | -57.2% | — | — |
| Intellia Therapeutics, Inc. (NTLA) | Healthcare | $1.56Bpit | $67.7M | 16.9% | — | -61.5% | — | — |
| Kura Oncology, Inc. (KURA) | Healthcare | $877.2Mpit | $67.5M | 25.2% | — | -160.0% | — | — |
| Spero Therapeutics, Inc. (SPRO) | Healthcare | $64.6Mpit | $66.8M | 39.2% | 12.8% | 14.5% | 27.3 | — |
| Exagen Inc. (XGN) | Healthcare | $176.1Mpit | $66.6M | 19.7% | -30.0% | -114.3% | — | — |
| Enanta Pharmaceuticals Inc. (ENTA) | Healthcare | $338.4Mpit | $65.3M | -3.4% | — | -126.5% | — | — |
| Cosmos Health Inc. (COSM) | Healthcare | $28.2Mpit | $65.3M | 19.9% | -29.3% | -103.9% | — | — |
| Concord Medical Services Holdings Ltd (CCM) | Healthcare | $16.0Mvendor | $65.0M | 26.6% | -20.4% | -5.0% | — | — |
| Nuvation Bio Inc. (NUVB) | Healthcare | $1.60Bpit | $62.9M | 699.0% | — | -66.9% | — | — |
| Tango Therapeutics, Inc. (TNGX) | Healthcare | $3.72Bpit | $62.4M | 48.3% | — | -29.3% | — | — |
| Meihua International Medical Technologies Co., Ltd. (MHUAF) | Healthcare | $5.6Mvendor | $61.8M | -36.2% | 11.0% | 3.6% | — | — |
| Journey Medical Corp (DERM) | Healthcare | $147.3Mpit | $61.2M | 11.1% | -18.7% | -35.9% | — | — |
| Fortress Biotech, Inc. (FBIO) | Healthcare | $64.7Mvendor | $61.2M | 11.1% | 11.1% | 11.0% | — | — |
| Champions Oncology, Inc. (CSBR) | Healthcare | $67.5Mpit | $59.4M | 4.4% | -2.0% | -28.9% | — | — |
| Alpha Pro Tech Ltd. (APT) | Healthcare | $56.6Mpit | $59.1M | 2.3% | 6.0% | 5.7% | 13.6 | — |
| Aytu Biopharma, Inc. (AYTU) | Healthcare | $21.3Mpit | $57.6M | -13.3% | -24.8% | -40.4% | — | — |
| CVRx, Inc. (CVRX) | Healthcare | $36.5Mpit | $56.7M | 10.4% | -94.1% | -135.6% | — | — |
| 908 Devices Inc. (MASS) | Healthcare | $474.9Mpit | $56.2M | 17.7% | 34.7% | 13.6% | — | — |
| Nektar Therapeutics (NKTR) | Healthcare | $1.32Bpit | $55.2M | -43.9% | — | -182.6% | — | — |
| Agios Pharmaceuticals, Inc. (AGIO) | Healthcare | $2.22Bpit | $54.0M | 48.0% | — | -34.6% | — | — |
| Q32 Bio Inc. (QTTB) | Healthcare | $257.5Mpit | $53.7M | — | 55.5% | 71.0% | 2.9 | — |
| Invivyd, Inc. (IVVD) | Healthcare | $179.8Mpit | $53.4M | 110.5% | -98.2% | -21.7% | — | — |
| Apyx Medical Corp (APYX) | Healthcare | $101.9Mpit | $52.8M | 9.9% | -21.2% | -75.6% | — | — |
| Protalix BioTherapeutics, Inc. (PLX) | Healthcare | $205.5Mpit | $52.7M | -1.2% | -12.5% | -13.7% | — | — |
| Iridex Corp. (IRIX) | Healthcare | $13.4Mpit | $52.7M | 8.2% | -8.4% | -90.1% | — | — |
Want more than a table?
Sign in to screen with custom filters (growth, ROIC, insider buying, short interest and 30+ more metrics), compare peers side by side, and get filing-grounded answers with citations. Free to start.
Start freeFundamentals from SEC EDGAR, as reported; valuation columns combine SEC filings with market data and are blanked where the two sources disagree. Informational only. Not investment advice.